(Q33703486)

28 July 2017

Mutations in p53, p53 protein overexpression and breast cancer survival (English)

1 reference

28 July 2017

1 reference

4

Mary Beth Terry

1 reference

28 July 2017

12

Mia M Gaudet

1 reference

28 July 2017

13

Susan L Teitelbaum

1 reference

28 July 2017

14

Alfred I Neugut

1 reference

28 July 2017

15

Regina M Santella

1 reference

28 July 2017

2

Marilie D Gammon

1 reference

28 July 2017

1

Pavel Rossner

1 reference

28 July 2017

10

Meenakshi Agrawal

1 reference

28 July 2017

5

Hanina Hibshoosh

1 reference

28 July 2017

6

Lorenzo Memeo

1 reference

28 July 2017

7

Mahesh Mansukhani

1 reference

28 July 2017

9

Gail Garbowski

1 reference

28 July 2017

Yu-Jing Zhang

3

1 reference

PubMed ID

19602056

28 July 2017

Chang-Min Long

series ordinal

8

1 reference

PubMed ID

19602056

28 July 2017

Tara S Kalra

series ordinal

11

1 reference

28 July 2017

16 October 2008

1 reference

Journal of Cellular and Molecular Medicine

28 July 2017

1 reference

28 July 2017

13

1 reference

28 July 2017

9B

1 reference

28 July 2017

3847-3857

1 reference

Surveyor nuclease-based detection of p53 gene mutations in haematological malignancy

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Mutation analysis of hCDC4 in AML cells identifies a new intronic polymorphism

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

p53 and breast cancer, an update

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Biomolecular markers of breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Surveyor Nuclease: a new strategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

The p53 story: layers of complexity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prognostic and predictive factors in early-stage breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Mutation detection using Surveyor nuclease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

p53 as a mutagen test in breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

p53 mutations and expression in breast carcinoma in situ

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prognostic and predictive value of p53 and p21 in breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Immunohistochemical analysis of p53 expression in primary breast carcinomas

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Weight gain prior to diagnosis and survival from breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Fruits, vegetables, and micronutrient intake in relation to breast cancer survival

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Assessing p53 in clinical contexts: unlearned lessons and new perspectives

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prognostic value of different factors in breast carcinoma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Spectrum of p53 tumor suppressor gene mutations and breast cancer survival

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

30 October 2018

TP53 and breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Correlation of p53 and cerbB2 expression and hormonal receptor status with clinicopathologic parameters in ductal carcinoma in situ of the breast.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

The IARC TP53 database: new online mutation analysis and recommendations to users

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prognostic value of cytosolic p53 protein in breast cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832100

Molecular markers in breast cancer: can we use c-erbB-2, p53, bcl-2 and bax gene expression as prognostic factors?

30 October 2018

1 reference

12 December 2020

In microdissected ductal carcinoma in situ, HER-2/neu amplification, but notp53 mutation, is associated with high nuclear grade and comedo histology

1 reference

12 December 2020

Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives

1 reference

12 December 2020

Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor

1 reference

12 December 2020

Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast

1 reference

12 December 2020

Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women

1 reference

12 December 2020

Risk factors for a causal intermediate and an endpoint: reconciling differences

1 reference

12 December 2020

Prognostic significance ofp53 mutation in breast cancer: Frequent detection of non-missense mutations by yeast functional assay

1 reference

12 December 2020

Association of breast cancer outcome with status of p53 and MDM2 SNP309

1 reference

12 December 2020

p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast

1 reference

12 December 2020

Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancer

1 reference

12 December 2020

TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis

1 reference

12 December 2020

The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer

1 reference

12 December 2020

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years

1 reference

12 December 2020

P53 in breast carcinomas: association between presence of mutation and immunohistochemical expression using a semiquantitative approach

1 reference

12 December 2020

10.1111/J.1582-4934.2008.00553.X

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference

PubMed ID

19602056